Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-26

Clinical Trial Update: Versartis International Trial in Adults With Long-Acting Growth Hormone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for adults with growth hormone deficiency evaluating a long-acting growth hormone treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Versartis Inc. | Conditions: Adult Growth Hormone Deficiency | Phase 2 | Status: COMPLETED